Rituximab-induced hypersensitivity pneumonitis in a kidney transplant patient

Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that has been associated with delayed pulmonary toxicity. In patients receiving RTX, hypersensitivity pneumonitis, although rare, should be considered in the appropriate clinical and radiographic setting. The authors present a case of hyper...

ver descrição completa

Detalhes bibliográficos
Autor principal: Silva,Natália (author)
Outros Autores: Ribeiro,Catarina Isabel (author), Almeida,Manuela (author), Malheiro,Jorge (author), Pedroso,Sofia (author), Martins,Maria La Salete (author), Dias,Leonídio (author), Henriques,António Castro (author), Cabrita,António (author)
Formato: report
Idioma:eng
Publicado em: 2020
Assuntos:
Drug-induced lung disease
hypersensitivity pneumonitis
kidney transplant
rituximab
Texto completo:http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692020000300010
País:Portugal
Oai:oai:scielo:S0872-01692020000300010
Descrição
Resumo:Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that has been associated with delayed pulmonary toxicity. In patients receiving RTX, hypersensitivity pneumonitis, although rare, should be considered in the appropriate clinical and radiographic setting. The authors present a case of hypersensitivity pneumonitis associated with a single dose of RTX treatment in a kidney transplanted patient with acute antibody-mediated rejection.

Registos relacionados